Bionow is delighted to announce the winners of the 2012 Bionow Annual Awards. The winners were presented at the Bionow Annual Awards Dinner which took place on 29th November 2012 at The Mere Golf Resort and Spa. The awards dinner was attended by over 280 executives from the biomedical industry and is the highlight of the biomedical calendar.
The prestigious event was hosted by Dr John Stageman OBE, Chair of Bionow and Geoff Davison, CEO of Bionow. Oliver Rausch, Programme Director at the NIHR Office for Clinical Infrastructure (NOCRI) was the guest speaker.
The judging panel which decided the winners consisted of representatives from each of the award sponsors and considered over 60 applications. The panel was chaired by Dr John Stageman along with Amy Harris of UL EduNeering, Graham Bond of Baker Tilly, Phil Sizer of Novartis, Elizabeth Delaney of DWF, Kevin Giles of Waters Corporation and Richard Deed of TRUSTECH.
The winners of the awards are:
Company of the Year – Sponsored by AstraZeneca
Winner: Eden Biodesign
Service Company of the Year – Sponsored by Bionow
Winner: Euprotec Ltd
Investment Deal of the Year – Sponsored by DWF
Winner: Clinigen Group plc
Biomedical Project of the Year – Sponsored by Waters Corporation
Winner: University of Manchester, Microsensor
Product or Service of the Year – Sponsored UL EduNeering
Winner: Biofortuna Ltd
Healthcare Project of the Year – Sponsored by TRUSTECH
Winner: Phagenesis Ltd
Promising Technologist of the Year – Sponsored by Novartis Vaccines and Diagnostics
Winner: Dr Nick Bryan, CellCap Technologies Ltd
Start-Up Company of the Year – Sponsored by Baker Tilly
Winner: Incanthera Ltd
Geoff Davison, CEO of Bionow Ltd said “Bionow is delighted to have hosted the 11th annual awards dinner especially since the event proved to be our most successful ever with over 280 attendees. I would like to give particular thanks to the award and event sponsors, our corporate sponsors and dinner guests and congratulate all of the winners. The strength and depth of the cluster and diversity of applications applications made this years judging as difficult as ever and the winners represent the cream of one of the leading clusters of biomedical businesses in the UK.”